[Pharmacological and therapeutic features of cerebral ischemic conditions].
Lechner
H
H
Department of Neurology, University of Graz, Austria.
Schmidt
R
R
D001241:Aspirin / Q000627:therapeutic use; D001783:Blood Flow Velocity; D001809:Blood Viscosity; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D002560:Cerebrovascular Circulation; D003131:Combined Modality Therapy; D005340:Fibrinogen / Q000032:analysis; D006400:Hematocrit; D006438:Hemodilution; D006801:Humans; D010431:Pentoxifylline / Q000627:therapeutic use; D010974:Platelet Aggregation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D005340:Fibrinogen; D001241:Aspirin; D010431:Pentoxifylline
Aspetti farmacologici e terapeutici nei disturbi ischemici cerebrali.